Researchers are working to redefine diagnosis and treatment with data-driven tools aimed at identifying patients earlier and ...

Virtual visits and remote monitoring are redefining how patients manage chronic conditions—boosting access, engagement, and outcomes.

The percentage of patients with bronchiectasis receiving brensocatib who did not have pulmonary exacerbations was 8.2 percentage points higher vs placebo. HealthDay News — For patients with ...

The 18-meter walk test (18MWT) effectively evaluates disease severity and predicts clinical outcomes in pulmonary arterial ...

idiopathic pulmonary arterial hypertension; neoplastic, hematologic, and immune diseases with systemic involvement, a history of pneumothorax and lobectomy. Additional exclusion criteria were ...

Respiratory diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and lung cancer, exhibit elevated death rates and pathological intricacy, requiring ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterised by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs ...

Additionally, the researchers envision improving these new microglia so they can, for example, produce therapeutic substances directly within the brain to actively combat disease. The study was ...

Half of pulmonary hypertension specialists from states with abortion bans said at least 1 of their patients had died due to complications of pregnancy or childbirth. Abortion bans in the United States ...

The most frequent risk factors were obesity (n=124; 39%), previous venous thromboembolism (n=78; 25%), active infection (n=43; 14%), chronic pulmonary disease (n=37; 12%), recent orthopedic surgery ...